Acquired HER2 mutations in ER ⁺ metastatic breast cancer confer resistance to estrogen receptor–directed therapies

Utthara Nayar, Ofir Cohen, Christian Kapstad, Michael S. Cuoco, Adrienne G. Waks, Seth A. Wander, Corrie Painter, Samuel Freeman, Nicole S. Persky, Lori Marini, Karla Helvie, Nelly Oliver, Orit Rozenblatt-Rosen, Cynthia X. Ma, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle

Research output: Contribution to journal › Letter › peer-review